Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy
NCT ID: NCT05887505
Last Updated: 2023-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2023-06-09
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peri-operative Vitamin D Therapy for Hepatectomy
NCT05650151
The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List
NCT01575717
Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients
NCT04111146
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
NCT01956864
Vitamin D Supplementation in Cirrhotic Patients
NCT02009748
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D group
Oral supplementation of 1,728,000 IU vitamin D3 in 3 days
Vitamin D
Oral supplementation of 576,000IU/day vitamin D3 in 3 consecutive days
Placebo Group
Oral supplementation of placebo in 3 days
Placebo
Oral supplementation of placebo in 3 consecutive days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
Oral supplementation of 576,000IU/day vitamin D3 in 3 consecutive days
Placebo
Oral supplementation of placebo in 3 consecutive days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2.Sign the informed consent
Exclusion Criteria
* 2\. Consume calcium tablets within 2 weeks before operation
* 3\. Sarcoidosis, multiple myeloma
* 4\. Pregnant women or plan to become pregnant within 3 months after surgery
* 5\. Autoimmune hepatitis (AIH)
* 6\. Early liver recurrence
* 7\. Used to participate in other clinical trials
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taoyuan General Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TYGH111086
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.